Онкология
2290 статей · 70 журналов
Журналы подкатегории (70)
- EJC Skin Cancer · Elsevier (91)
- Biochimica et Biophysica Acta: Reviews on Cancer · Elsevier (90)
- Blood Neoplasia · Elsevier (90)
- The Lancet Oncology · Elsevier (89)
- Cancer Treatment and Research Communications · Elsevier (85)
- European Journal of Surgical Oncology · Elsevier (85)
- Journal of Thoracic Oncology · Elsevier (83)
- Brachytherapy · Elsevier (81)
- Cancer Epidemiology · Elsevier (81)
- International Journal of Gynecological Cancer · Elsevier (80)
- Asia-Pacific Journal of Clinical Oncology · Wiley (72)
- Lung Cancer · Elsevier (69)
- European Journal of Cancer · Elsevier (68)
- Critical Reviews in Oncology/Hematology · Elsevier (67)
- Leukemia Research Reports · Elsevier (66)
- Surgical Oncology Clinics of North America · Elsevier (66)
- Urologic Oncology: Seminars and Original Investigations · Elsevier (64)
- Gynecologic Oncology Reports · Elsevier (62)
- Bulletin du Cancer · Elsevier (59)
- Translational Oncology · Elsevier (58)
- Blood Reviews · Elsevier (54)
- Journal of the National Cancer Center · Elsevier (54)
- The Journal of Liquid Biopsy · Elsevier (53)
- Leukemia Research · Elsevier (52)
- Cancer Letters · Elsevier (51)
- Trends in Cancer · Elsevier (49)
- JACC: CardioOncology · Elsevier (46)
- Surgical Oncology Insight · Elsevier (43)
- Clinical Breast Cancer · Elsevier (39)
- ESMO Open · Elsevier (38)
- Cancer Pathogenesis and Therapy · Elsevier (37)
- Clinical Lung Cancer · Elsevier (33)
- Current Problems in Cancer: Case Reports · Elsevier (30)
- Journal of Geriatric Oncology · Elsevier (30)
- Journal of Bone Oncology · Elsevier (29)
- Intelligent Oncology · Elsevier (20)
- Precision Radiation Oncology · Wiley (20)
- Current Problems in Cancer · Elsevier (17)
- Immuno-Oncology and Technology · Elsevier (16)
- Best Practice & Research Clinical Haematology · Elsevier (12)
- npj Precision Oncology · Springer Nature (12)
- MedComm - Oncology · Wiley (10)
- European Journal of Cancer: Supplement · Elsevier (9)
- Nature Reviews Cancer · Springer Nature (9)
- British Journal of Cancer · Springer Nature (8)
- Nature Reviews Clinical Oncology · Springer Nature (8)
- Cancer Cytopathology · Wiley (5)
- BMC Cancer · Springer Nature (0)
- Breast Cancer Research · Springer Nature (0)
- Breast Cancer Research and Treatment · Springer Nature (0)
- Cancer Cell International · Springer Nature (0)
- Cancer Chemotherapy and Pharmacology · Springer Nature (0)
- Cancer and Metastasis Reviews · Springer Nature (0)
- Cardio-Oncology · Springer Nature (0)
- Cellular Oncology · Springer Nature (0)
- Clinical and Translational Oncology · Springer Nature (0)
- Current Breast Cancer Reports · Springer Nature (0)
- Current Hematologic Malignancy Reports · Springer Nature (0)
- Current Oncology Reports · Springer Nature (0)
- Immuno-Oncology · Springer Nature (0)
- Indian Journal of Gynecologic Oncology · Springer Nature (0)
- Indian Journal of Surgical Oncology · Springer Nature (0)
- Journal of Cancer Research and Clinical Oncology · Springer Nature (0)
- Journal of Gastrointestinal Cancer · Springer Nature (0)
- Journal of Mammary Gland Biology and Neoplasia · Springer Nature (0)
- Journal of the Egyptian National Cancer Institute · Springer Nature (0)
- Molecular Cancer · Springer Nature (0)
- Oncology and Therapy · Springer Nature (0)
- Strahlentherapie und Onkologie · Springer Nature (0)
- best practice onkologie · Springer Nature (0)
- Impact of primary tumor location on survival outcomes and recurrence patterns in patients with stage III non-small cell lung cancer: A retrospective observational study
- Pretreatment lactate dehydrogenase, but not magnesium or neutrophil-to-lymphocyte ratio, is independently associated with grade ≥3 chemotherapy toxicity in breast cancer: prediction-model development and internal validation in 400 patients
- Global, G20, and China burden of malignant neoplasms of bone and articular cartilage from 1990 to 2050: trends, projections, and ecological associations with healthcare expenditure
- Association of neoadjuvant radiotherapy with 10-year survival outcomes in large cell lung cancer: A retrospective SEER-based study
- Temporal trends in cancer among the oldest-old: incidence, stage at diagnosis, treatment and survival. A population-based study, Hérault, France, 1990–2022
- Prognostic impact of residual viable tumor percentage on non-small cell lung cancer recurrence after neoadjuvant immunochemotherapy
- Childhood cancer incidence rates outside major U.S. metropolitan statistical areas (MSAs), 1999–2022: A CDC WONDER descriptive analysis
- Epithelial FOXP3: The Silent Spark That Lights the Fire of Pancreatic Cancer
- Emerging cancer incidence trends in younger generations: age-specific trends and birth cohort effects from 25 years of Korean Cancer Registry data
- Polyploid giant cancer cells: A hidden cost of Aurora Kinase inhibitors and antimitotic therapies revealed through the PGCC Explorer
- Sociodemographic factors associated with advanced-stage diagnosis of head and neck cancers in Estonia: A register-based study
- P0112: Total Reference Air Kerma and Clinical Toxicity in Template-Guided Interstitial HDR Ir-192 Brachytherapy for Gynecologic Malignancies: A Single-Institution Pilot Study
- P0113: Rate of Perioperative Complications Requiring Emergency Room Visits for Patients Undergoing Intracavitary High Dose Rate Brachytherapy in a Freestanding Outpatient Clinic: A Single Institutional Experience
- P0114: Dosimetric Comparison of Adaptive External Beam Radiotherapy Boost versus HDR Brachytherapy in Gynecological Cancers
- P0115: Proposed Clinical Workflows for HDR Gynecological Brachytherapy Using Linac-Integrated Hypersight CBCT
- Tumor-associated neutrophils crosstalk with non-cancerous components of the gastrointestinal tumor microenvironment
- P0116: External Validation of Needle Configuration Selection Tool for High Dose Rate Brachytherapy for Treatment of Cervical Cancer
- Mechanistic insights into lysosomal stress response network in carcinogenesis and therapeutic opportunities
- Validation of ELN 2024 genetic classification in patients with AML treated with HMA-based regimens: PETHEMA registry study
- Rethinking glioma-associated senescence: Drivers of heterogeneity and therapeutic resistance
- Temporal and spatial molecular heterogeneity of gastric cancer: Roles of post-translational modifications
- Hypomethylating agents–venetoclax as salvage therapy for relapse of AML and MDS after allogeneic HCT
- Self-supervised learning can distinguish myelodysplastic neoplasms from clinical mimics using bone marrow biopsies
- Expression of RUNX1::RUNX1T1 deregulates the proteome, induces C/EBPβ suppression, and blocks myeloid differentiation
- Bone marrow immunosuppressive states associate with survival after guadecitabine and atezolizumab therapy in HMA-R/R MDS
- Targeting cancer epigenetic pathways with small-molecule modulators for potential therapeutic purposes
- Incidental bladder cancer detected by routine cystoscopy before robot-assisted radical prostatectomy: A multicenter retrospective study
- Epidemiological trends in penile cancer and the evolving role of dynamic sentinel lymph node biopsy
- Corrigendum to “A 2-center review of histopathology of variants of upper urinary tract urothelial carcinoma and their impact on clinical outcomes” [Urologic Oncology: Seminars and Original Investigations 42 (2024) 333.e15−333.e20]
- Corrigendum to “Differential mTOR pathway profiles in bladder cancer cell line subtypes to predict sensitivity to mTOR inhibition” Volume 35, Issue 10, October 2017, Pages 593-599